01 5Takhzyro
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2019 Revenue in Millions : 545
2018 Revenue in Millions : 0
Growth (%) : New launch
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2020 Revenue in Millions : 808
2019 Revenue in Millions : 556
Growth (%) : 45
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2021 Revenue in Millions : 838
2020 Revenue in Millions : 775
Growth (%) : 17
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2022 Revenue in Millions : 1,093
2021 Revenue in Millions : 838
Growth (%) : 30
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2023 Revenue in Millions : 1,168
2022 Revenue in Millions : 1,093
Growth (%) : 21
LOOKING FOR A SUPPLIER?
